Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries
- 30 April 2020
- journal article
- review article
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (3), 241-246
- https://doi.org/10.1016/j.dsx.2020.03.011
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)Journal of Biological Chemistry, 2016
- Diabetic Retinopathy Is Strongly Predictive of Cardiovascular Autonomic Neuropathy in Type 2 DiabetesJournal of Diabetes Research, 2016
- The enigma of the clandestine association between chloroquine and HIV‐1 infectionHIV Medicine, 2015
- Lack of Protection Against Ebola Virus from Chloroquine in Mice and HamstersEmerging Infectious Diseases, 2015
- Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trialThe Lancet Infectious Diseases, 2011
- A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese AdultsPLoS Neglected Tropical Diseases, 2010
- Chloroquine Administration Does Not Prevent Nipah Virus Infection and Disease in FerretsJournal of Virology, 2009
- Chloroquine is effective against influenza A virus in vitro but not in vivoInfluenza and Other Respiratory Viruses, 2007
- Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral ActivitiesJournal of Medicinal Chemistry, 2006
- Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cellsAntimicrobial Agents and Chemotherapy, 1990